Jonathan Hauptman
- Pharmacology top 0.1%
- Pharmacology and Obesity Treatment 17
-
- Diabetes Treatment and Management 4
- Pharmacy top 0.5%
- Obesity and Health Practices 2
- Physiology top 1%
- Diet and metabolism studies 2
-
- Muscle metabolism and nutrition 6
-
- Obesity, Physical Activity, Diet 3
-
- Metabolism, Diabetes, and Cancer 2
-
- Veterinary Medicine and Surgery 1
- Co-authors
- Mark BoldrinLars SjöströmJarl TorgersonCharles LucasSteven B. HeymsfieldJain ChungSarah HamplJean‐Pierre Chanoine
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Jonathan Hauptman
19 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 99
- Pharmacology 3.0k
- Endocrinology, Diabetes and Metabolism 2.0k
- Pharmacy 382
- Physiology 1.7k
- Endocrine and Autonomic Systems 264
Countries citing papers authored by Jonathan Hauptman
This map shows the geographic impact of Jonathan Hauptman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Hauptman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Hauptman more than expected).
Fields of papers citing papers by Jonathan Hauptman
This network shows the impact of papers produced by Jonathan Hauptman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Hauptman. The network helps show where Jonathan Hauptman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan Hauptman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 55 | |
| 2 | 2007 | 13 | |
| 3 | 2006 | 34 | |
| 4 | 2005 | 9 | |
| 5 | 2005 | 412 | |
| 6 | XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Studybreakdown → | 2004 | 1284 |
| 7 | 2001 | 77 | |
| 8 | 2001 | 1 | |
| 9 | 2000 | 23 | |
| 10 | 2000 | 286 | |
| 11 | 2000 | 1 | |
| 12 | 2000 | 264 | |
| 13 | Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistatbreakdown → | 1999 | 705 |
| 14 | 1999 | 66 | |
| 15 | 1999 | 225 | |
| 16 | 1998 | 13 | |
| 17 | 1998 | 472 | |
| 18 | 1994 | 210 | |
| 19 | Adrenergic blockade in pheochromocytoma. | 1983 | 12 |
| 20 | 1983 | 21 |
About Jonathan Hauptman
Jonathan Hauptman is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pharmacy, having authored 20 papers that have together received 4.2k indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (17 papers), Muscle metabolism and nutrition (6 papers), Diabetes Treatment and Management (4 papers), Obesity, Physical Activity, Diet (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Diet and metabolism studies (2 papers), Obesity and Health Practices (2 papers) and Veterinary Medicine and Surgery (1 paper). The work is most often cited by research in Pharmacology (3.0k citations), Endocrinology, Diabetes and Metabolism (2.0k citations) and Pharmacy (382 citations). Jonathan Hauptman has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Mark Boldrin, Lars Sjöström, Jarl Torgerson, Charles Lucas, Steven B. Heymsfield, Jain Chung, Sarah Hampl, Jean‐Pierre Chanoine, Craig L. Jensen and David C. Robbins. Their work appears in journals such as JAMA, American Journal of Clinical Nutrition and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.